Understanding the disease – Researching therapies
Research

The Epidermolysis Bullosa Research Institute (EB RI) is a translational research and development institute dedicated to improving the lives of “butterfly children”. Based on the valuable work of the research department of the EB House Austria, the EB RI has developed into an innovation center and is expanding its focus to drug development research. 

The mission of the research team is to support EB patients by delivering life-enhancing treatments. To achieve this, they build on their deep understanding of the disease, cutting-edge research, precision medicine and strategic collaborations.
Through intensive cooperation between physicians and researchers worldwide, new approaches to therapeutic options are developed, which are to be transferred from the lab to the clinic and hence to patients as fast and safe as possible.

EB Research

Due to the complex clinical features of EB, research at the EB RI focuses on various key areas.